HONOLULU (KHON2) — On Friday Sept. 24, the Facilities for Illness Management and Prevention Director Rochelle Walensky, endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) suggestion on a booster shot of the Pfizer-BioNTech COVID-19 vaccine in sure populations, and in excessive danger occupational settings.

Discover extra COVID-19 information: instances, vaccinations on our Coronavirus Information web page

“I consider we are able to finest serve the nation’s public well being wants by offering booster doses for the aged, these in long-term care amenities, individuals with underlying medical situations, and for adults at excessive danger of illness from occupational and institutional exposures to COVID-19,” Walensky mentioned. “This aligns with the FDA’s booster authorization and makes these teams eligible for a booster shot.

“Right this moment, ACIP solely reviewed information for the Pfizer-BioNTech vaccine. We’ll handle, with the identical sense of urgency, suggestions for the Moderna and J&J vaccines as quickly as these information can be found,” she mentioned.

Take a look at what’s occurring across the nation on our Nationwide Information web page

On Wednesday, Sept. 22, the U.S Meals and Drug Administration (FDA) amended and accredited the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to permit to be used of a single booster dose, which must be administered at the least six months after the primary main collection.

In line with the FDA, the first collection consists of people 65 years of age and older; 18 by means of 64 years of age at excessive danger of extreme COVID-19; and 18 by means of 64 years of age whose frequent institutional or occupational publicity to SARS-CoV-2 places them at excessive danger of great problems of COVID-19.

FDA mentioned the authorization applies solely to the Pfizer-BioNTech COVID-19 Vaccine.